|Year : 2020 | Volume
| Issue : 6 | Page : 550-551
A rare case of secondary pulmonary alveolar proteinosis with adenocarcinoma of lung with retroviral disease
Aditi Dushyant Punwani, Sonal Prabhakar Karpe, Amita Umesh Athavale, Prabodh D Garg, Mahesh R Jansari
Department of Chest Medicine, EPRC, KEM Hospital, Mumbai, Maharashtra, India
|Date of Submission||12-Mar-2020|
|Date of Acceptance||02-Apr-2020|
|Date of Web Publication||30-Oct-2020|
Sonal Prabhakar Karpe
Department of Chest Medicine, EPRC, KEM Hospital, Mumbai, Maharashtra
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Punwani AD, Karpe SP, Athavale AU, Garg PD, Jansari MR. A rare case of secondary pulmonary alveolar proteinosis with adenocarcinoma of lung with retroviral disease. Lung India 2020;37:550-1
|How to cite this URL:|
Punwani AD, Karpe SP, Athavale AU, Garg PD, Jansari MR. A rare case of secondary pulmonary alveolar proteinosis with adenocarcinoma of lung with retroviral disease. Lung India [serial online] 2020 [cited 2020 Nov 28];37:550-1. Available from: https://www.lungindia.com/text.asp?2020/37/6/550/299652
Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by alveolar accumulation of abnormal surfactant. We report, so far, the first case of a patient with retroviral disease presenting with secondary PAP and adenocarcinoma of the lung together from India.
A 35-year-old man, diagnosed with human immunodeficiency virus infection two years ago, on antiretroviral therapy, presented with complaints of dyspnea, cough, fever, and weight loss. He was treated with antituberculous therapy since six months on presumptive diagnosis of tuberculosis based on clinical symptoms and radiology, chest X-ray [Figure 1], and computed tomography (CT) scan findings.
|Figure 1: Chest X-ray showing bilateral alveolar opacities in all lung fields and right lower zone consolidation|
Click here to view
Sputum reports for all infections were negative. Bronchoalveolar lavage (BAL) was performed. The BAL fluid showed alveolar macrophages 27%, lymphocytes 32%, neutrophils 41%, and sediment on standing periodic acid stain positive and diastase resistant, suggestive of PAP, negative for infections including tuberculosis, Pneumocystis carinii pneumonia (PCP), and malignancy. He refused a therapeutic lavage and transbronchial biopsy.
On follow-up, about 2 months later, he presented with increased symptoms. A repeat CT scan revealed an increase in ground glass opacities and increased consolidation in the right lower lobe [Figure 2]. A transbronchial biopsy and washings were taken. Bronchial washings were negative for infective etiology such as tuberculosis, PCP, bacteria, fungi, and atypical mycobacteria. Histopathological examination was suggestive of adenocarcinoma of the lung staining focally positive for thyroid transcription factor-1. The patient was referred to a higher oncology center for further management.
|Figure 2: Computed tomography scan images showing consolidation and ground glass appearance bilaterally|
Click here to view
Secondary PAP has been reported in association with systemic disorders associated with immunodeficiency, including acquired immunodeficiency syndromes. In patients with acquired immunodeficiency syndrome (AIDS), PAP may be result of the primary pathology or due to super added infections like PCP.
The altered immune function in AIDS patients leads to an altered ability of the macrophages to clear out accumulated lipoid material within alveoli and an increased susceptibility to opportunistic infections. A systematic review of Indian cases of PAP was done by Hadda et al. in 2016. As per this review, out of 30 reported cases, 24 had primary PAP. Remaining six patients were labeled as secondary PAP related to cyclosporine or mycophenolate, cotton dust exposure, sandstone exposure, glass cutting, and fiber exposure or nocardia. Concomitant infections were seen in four patients, Mycobacterium tuberculosis in two and P. carinii in two patients.
Similarly, Khan et al. also published a case series from another Indian tertiary care hospital. This study had five patients with idiopathic PAP and one patient with secondary PAP due to Nocardia.
In neither of these two studies was a case with AIDS, PAP, and pulmonary cancer reported.
PAP has been described in association with cancers, both pulmonary (small cell cancer, non-small cell cancer, squamous cell carcinoma, and adenocarcinoma) and extra-pulmonary.
The lung cancer may occur prior to coincidentally with or after many years of diagnosis of PAP.
In both PAP and adenocarcinoma, the alveoli are filled with a low-density material, the alveolar septa thicken but the underlying parenchymal architecture remains normal.
Solid lung cancers causing PAP have not been extensively studied. As the patient was otherwise tolerating his antiretroviral therapy over two years with a normal CD4 count, considering the slow progression of the disease, the PAP was likely secondary to malignancy.
The importance of diagnosing the etiology for the management of a disease cannot be overemphasized especially in a rare disorder like PAP. However, due to the complex pathophysiology of PAP, diagnostic modalities to differentiate the underlying cause in presence of two potential causes of secondary PAP are lacking. The presentation of retroviral disease with adenocarcinoma of lung with PAP is extremely rare and to the best of our knowledge, this is the first reported case in India.
We would like to thank doctors and nursing and supporting staff of Intensive Respiratory Care Unit, Department of Chest Medicine and EPRC.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Feng Y, Zhao J, Yang Q, Xiong W, Zhen G, Xu Y, et al
. Pulmonary melanoma and “crazy paving” patterns in chest images: A case report and literature review. BMC Cancer 2016;16:592.
Floarea-Strat A, Grigoraş A, Dobrescu G, Grigoraş C, Creţeanu M, Teodorescu I. Pulmonary alveolar proteinosis in AIDS patients. Rev Med Chir Soc Med Nat Iasi 2004;108:287-9.
Hadda V, Tiwari P, Madan K, Mohan A, Gupta N, Bharti SJ, et al
. Pulmonary alveolar proteinosis: Experience from a tertiary care center and systematic review of Indian literature. Lung India 2016;33:626-34.
] [Full text]
Khan A, Agarwal R, Aggarwal AN, Bal A, Sen I, Yaddanapuddi LN, et al
. Experience with treatment of pulmonary alveolar proteinosis from a tertiary care centre in north India. Indian J Chest Dis Allied Sci 2012;54:91-7.
Su KC, Lay SL, Perng RP, Chang SC, Chen YM. Lung cancer may develop subsequently or coincidently with pulmonary alveolar proteinosis. Lung Cancer 2007;58:144-8.
Iwakami S, Fujii M, Tsutsumi T, Sekimoto Y, Jo H, Hara M, et al
. Autoimmune pulmonary alveolar proteinosis with primary lung cancer in a patient of very advanced years. Geriatr Gerontoly Int 2015;15:666-7.
[Figure 1], [Figure 2]